Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$73 Mln
P/E Ratio
350
P/B Ratio
0.75
Industry P/E
31.14
Debt to Equity
0.02
ROE
0 %
ROCE
--
Div. Yield
0 %
Book Value
4.66
EPS
0.01
CFO
$321.54 Mln
EBITDA
$339.34 Mln
Net Profit
$223.55 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
PetMed Express (PETS)
| -27.39 | -16.47 | -29.15 | -15.25 | -47.47 | -36.78 | -14.79 |
|
BSE Sensex*
| 2.52 | 3.37 | 6.44 | 8.80 | 12.18 | 20.37 | 11.43 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
PetMed Express (PETS)
| -36.01 | -57.29 | -29.93 | -21.21 | 36.31 | 1.12 | -48.69 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 29.58 | 6,373.22 | 8.24 | -52.99 | |
| 61.15 | 3,421.14 | 36.32 | 15.83 | |
| 48.58 | 1,114.00 | 31.14 | 20.66 | |
| 363.48 | 1,283.82 | 32.45 | -- |
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers... non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida. Read more
CEO, President & Director
Mr. Mathew N. Hulett
CEO, President & Director
Mr. Mathew N. Hulett
Headquarters
Delray Beach, FL
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of PetMed Express Inc (PETS) stood at $ 193 Mln as on 31-Dec-24
The share price of PetMed Express Inc (PETS) is $3.50 (NASDAQ) as of 25-Apr-2025 16:00 EDT. PetMed Express Inc (PETS) has given a return of -47.47% in the last 3 years.
PetMed Express Inc (PETS) has a market capitalisation of $ 73 Mln as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of PetMed Express Inc (PETS) is 0.75 times as on 25-Apr-2025, a 77% discount to its peers’ median range of 3.28 times.
The P/E ratio of PetMed Express Inc (PETS) is 350.00 times as on 25-Apr-2025, a 1024% premium to its peers’ median range of 31.14 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the PetMed Express Inc (PETS) and enter the required number of quantities and click on buy to purchase the shares of PetMed Express Inc (PETS).
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
The CEO & director of Mr. Mathew N. Hulett. is PetMed Express Inc (PETS), and CFO & Sr. VP is Mr. Mathew N. Hulett.
There is no promoter pledging in PetMed Express Inc (PETS).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
616
|
|
|
321
|
|
|
127
|
|
|
110
|
| PetMed Express Inc. (PETS) | Ratios |
|---|---|
|
Return on equity(%)
|
0.38
|
|
Operating margin(%)
|
0.41
|
|
Net Margin(%)
|
0.14
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of PetMed Express Inc (PETS) was $0 Mln.
$-0.02
(
